Fig. 1.

(A) Abdominopelvic computed tomography (CT) shows a low- density 2.3 cm mass (before radiofrequency ablation (RFA). (B) low-density lesion on the portal phase in S5 of the liver (post RFA). (C) Abdominopelvic CT reveals a 5.7 cm heterogeneous mass. (D) T2-weighted magnetic resonance image shows a high signal intensity mass in right ovary.

Fig. 1.

(A) Tissue from ovarian mass (Hematoxylin and Eosin Staining (H-&E) stain, x2). The ovarian mass compose of fragmented ovarian cortex, and tumor mass with hemorrhage. (B) Mid-magnification (H&-E stain, x20). The ovarian mass is of hepatocellular carcinoma with hemorrhage. (Long arrow: HCC, short arrow: Ovary)

Fig. 3.

Higher magnification (A, H&-E; B, hepatocyte specific antigen immunohistochemistry (HSA); C, Carcinoembryonic Antigen immunohistochemistry (CEA), x200). (A) The hepatocellular carcinoma metastatic to vary shows thick trabecular and occasionally pseudo glandular architecture, clear cell type and nuclear grade 2/3 (common/worst). (B) Representing clear HAS (+) and (C) bile canalicular type of CEA.

References

• 1.McGahan JP, Browning PD, Brock JM, Tesluk H. Hepatic ablation using radiofrequency electrocautery. Invest Radiol 1990;25:267–70.ArticlePubMed
• 2.Rossi S, Fornari F, Pathies C, Buscarini L. Thermal lesions induced by 480 KHz localized current field in guinea pig and pig liver. Tumori 1990;76:54–7.ArticlePubMed
• 3.Llovet JM, Vilana R, Brú C, Bianchi L, Salmeron JM, Boix L, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001;33:1124–9.ArticlePubMed
• 4.Stigliano R, Marelli L, Yu D, Davies N, Patch D, Burroughs AK. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev 2007;33:437–47.PubMed
• 5.Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999;210:655–61.ArticlePubMed
• 6.Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G, et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002;89:1206–22.ArticlePubMed
• 7.Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multi-center study. Radiology 2003;226:441–51.ArticlePubMed
• 8.De Baère T, Risse O, Kuoch V, Dromain C, Sengel C, Smayra T, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 2003;181:695–700.ArticlePubMed
• 9.Jaskolka JD, Asch MR, Kachura JR, Ho Cs, Ossip M, Wong F, et al. Needle tract seeding after radiofrequency ablation of hepatic tumors. J Vasc Interv Radiol 2005;16:485–91.ArticlePubMed
• 10.Chen MH, Wei Y, Yan K, Gao W, Dai Y, Huo L, et al. Treatment strategy to optimize radiofrequency ablation for liver malignancies. J Vasc Interv Radiol 2006;17:671–83.ArticlePubMed
• 11.Shirato K, Morimoto M, Tomita N, Kokawa A, Sugi, ori K, Saito T, et al. Hepatocellular carcinoma: a case of extrahepatic seeding after percutaneous radiofrequency ablation using an expandable needle electrode. Hepatogastroenterology 2002;49:897–9.PubMed
• 12.YW C, SJ P, HY J, JY K, Lee JI, MJ K, et al. A case of needle tract seeding of hepatocellular carcinoma after radiofrequency ablation. Inje Med J 2006;27:127–32.
• 13.Markenson D. The treatment of children exposed to pathogens linked to bioterrorism. Infect Dis Clin North Am 2005;19:731–45.ArticlePubMed
• 14.Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228:235–40.ArticlePubMed
• 15.Gervais DA, Goldberg SN, Brown DB, Soulen MC, Millward SF, Rajan DK. Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors. J Vasc Interv Radiol 2009;20:S342–7.ArticlePubMed
• 16.Lee JM, Park KM, Lee SY, Choi J, Hwang DW, Lee YJ. Metastasis of hepatocellular carcinoma to the ovary: a case report and review of the literature. Gut Liver 2011;5:543–7.ArticlePubMedPMC

Figure & Data

References

Citations

Citations to this article as recorded by  

• A case of hepatocellular carcinoma with metastasis to the ovary
  Haruka AKAJI (KAJIO), Tomoko KURITA, Ryosuke TAJIRI, Hiroshi HARADA, Taeko UEDA, Kiyoshi YOSHINO, Haruko OKA, Nobuyuki TERADO, Aya NAWATA, Yusuke MATSUURA
  The Journal of the Japanese Society of Clinical Cytology.2023; 62(6): 300.     CrossRef
• Long-term survival of 11 years with multidisciplinary therapy for hepatocellular carcinoma metastasis to the ovary and peritoneum: a case report
  Satoko Motegi, Takeshi Yokoo, Ryosuke Nozawa, Rie Azumi, Yuzo Kawata, Kohei Ogawa, Toru Setsu, Ken-ichi Mizuno, Koji Nishino, Hajime Umezu, Hirokazu Kawai, Takeshi Suda, Shuji Terai
  Clinical Journal of Gastroenterology.2021; 14(4): 1211.     CrossRef